Your browser doesn't support javascript.
loading
Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.
Pizzorno, G; Yee, L; Burtness, B A; Marsh, J C; Darnowski, J W; Chu, M Y; Chu, S H; Chu, E; Leffert, J J; Handschumacher, R E; Calabresi, P.
Affiliation
  • Pizzorno G; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Clin Cancer Res ; 4(5): 1165-75, 1998 May.
Article in En | MEDLINE | ID: mdl-9607574
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uracil / Uridine Phosphorylase / Enzyme Inhibitors Type of study: Prognostic_studies Limits: Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uracil / Uridine Phosphorylase / Enzyme Inhibitors Type of study: Prognostic_studies Limits: Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States